On February 27, 2023 FibroGen, Inc. (NASDAQ: FGEN) reported that Mark Eisner, M.D., M.P.H., Chief Medical Officer, will participate in a panel discussion at Cowen’s 43rd Annual Health Care Conference to be held in Boston on March 5 – 8, 2023. Details of the presentations are as follows (Press release, FibroGen, FEB 27, 2023, https://investor.fibrogen.com/news-releases/news-release-details/fibrogen-present-cowens-43rd-annual-health-care-conference [SID1234627724]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Panel Information:
Date: Wednesday, March 8, 2023
Panel topic: Respiratory/Infections
Time: 10:30 AM Eastern Time

A live audio webcast of the event will be available to investors and other interested parties on the "Events & Presentations" section of the FibroGen Investor webpage at www.fibrogen.com. A replay will be available for approximately 30 days.